Aurinia Pharmaceuticals AUPH Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Aurinia Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aurinia Pharmaceuticals's quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Aurinia Pharmaceuticals's quick ratio?
- Aurinia Pharmaceuticals (AUPH) reported quick ratio of 5× in Q1 2026.
- How has Aurinia Pharmaceuticals's quick ratio changed year-over-year?
- Aurinia Pharmaceuticals's quick ratio decreased by 4.6% year-over-year, from 5.3× to 5×.
- What is the long-term trend for Aurinia Pharmaceuticals's quick ratio?
- Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's quick ratio has grown at a -17.8% compound annual growth rate (CAGR), from 12.7× to 4.8×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.